MatriDx has signed a agreement with GoBroad Healthcare Group, to create a new situation of precision diagnosis and treatments on oncology.

Recently, Hangzhou Matridx biotechnology Co Ltd has signed a agreement with Go Broad Healthcare Group in Beijing Boren Hospital.

Dr. Wang Jun, founder and CEO of MatriDx, Mr. Zhang Jiecheng, general manager of GoBroad Healthcare Group, and the main leaders of both parties attended the signing ceremony. Based on this cooperation, the two parties will build the microbial mNGS technology platform, and promote microbial mNGS technology to a wider application, make precision diagnosis and treatment technology benefit the patients